The Adiponectin Receptor Agonist, ALY688: A Promising Therapeutic for Fibrosis in the Dystrophic Muscle

Duchenne muscular dystrophy (DMD) is one of the most devastating myopathies, where severe inflammation exacerbates disease progression. Previously, we demonstrated that adiponectin (ApN), a hormone with powerful pleiotropic effects, can efficiently improve the dystrophic phenotype. However, its prac...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubuisson, Nicolas, Versele, Romain, Davis-López de Carrizosa, Maria A., Selvais, Camille M., Noel, Laurence, Planchon, Chloé, Van den Bergh, Peter Y. K., Brichard, Sonia M., Abou-Samra, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453606/
https://www.ncbi.nlm.nih.gov/pubmed/37626911
http://dx.doi.org/10.3390/cells12162101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10453606/
https://www.ncbi.nlm.nih.gov/pubmed/37626911
http://dx.doi.org/10.3390/cells12162101

Ejemplares similares